NuVasive, Inc. Announces Third Quarter 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NuVasive Announces Third Quarter 2013 Financial Results

SAN DIEGO, CA--(Marketwired - Oct 29, 2013) - NuVasive, Inc. (NASDAQ: NUVA)

-- Third quarter 2013 revenue of $169.2 million; up 14.0% from third quarter 2012

-- Non-GAAP operating margin of 15.4%

-- GAAP net income of $7.5 million, or $0.16 per share

-- Non-GAAP net income of $18.3 million, or $0.39 per share

-- Increases 2013 guidance for revenue, non-GAAP operating margin, and non-GAAP earnings per share

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today financial results for the quarter ended September 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC